PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mustafa Raoof, MD
City of Hope Medical Center
Principal Investigator - Thanh H Dellinger, MD
City of Hope Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Medical Center
Duarte, California, United States
Thanh H. DellingerRecruiting - Mayo Clinic in Florida
Jacksonville, Florida, United States
Amit L. MercheaRecruiting - Northwell Health Cancer Institute at Huntington
Greenlawn, New York, United States
Richard L. WhelanRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Aug 2020
- Primary completion
- 5 Jan 2028
- Completion
- 5 Jan 2028
- Last update posted
- 10 Dec 2025
- Registered enrollment
- 49
- Registry id
- NCT04329494
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.